Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
130 hedge funds and large institutions have $487M invested in Amedisys in 2013 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 16 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
67% more call options, than puts
Call options by funds: $28.8M | Put options by funds: $17.3M
60% more capital invested
Capital invested by funds: $304M → $487M (+$182M)
56% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 34
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
6% more funds holding
Funds holding: 123 → 130 (+7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCA
KKR Credit Advisors
San Francisco,
California
|
+$32M |
| 2 |
D.E. Shaw & Co
New York
|
+$7.5M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$4.39M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$4.22M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$3.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.75M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$9.3M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$4.21M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.66M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3.59M |
AMED Hedge Fund Activity: Q3 2013 in Review
130 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2013, worth a combined $487M — up 60% from $304M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new AMED positions and 16 closed out — a net gain of 8 holders — while 53 added to existing stakes and 34 trimmed.
The largest buyer was KKR Credit Advisors, adding an estimated $32M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $9.75M sold.
- 130 institutional investors held Amedisys (AMED) as of Q3 2013, up from 123 in Q2 2013.
- Funds reported $487M of Amedisys stock for Q3 2013, up 60% quarter-over-quarter.
- 24 funds opened new Amedisys positions in Q3 2013 and 16 closed out, a net change of +8 holders.
- The largest Amedisys buyer in Q3 2013 was KKR Credit Advisors, an estimated $32M added.
- The largest Amedisys seller in Q3 2013 was Adage Capital Partners, an estimated $9.75M sold.
Based on aggregated 13F filings for Q3 2013.